🔵 WHO malaria guideline 2024 recommendations
Topic: G6PD Testing & Anti-Relapse Therapy for P. vivax and P. ovale
The G6PD status of patients shoud be used to guide admnstration of ether prmaquine or tafenoquine for
preventng relapse
Source: WHO guidelines for malaria 2024 Guideline.pdf
@HakimApps_Guideline
Topic: G6PD Testing & Anti-Relapse Therapy for P. vivax and P. ovale
The G6PD status of patients shoud be used to guide admnstration of ether prmaquine or tafenoquine for
preventng relapse
G6PD Testing
Qualitative Tests: Identify G6PD deficiency (70% activity.
Source: WHO guidelines for malaria 2024 Guideline.pdf
@HakimApps_Guideline